Merck KGaA and Millipore Announce Transaction – Video Interview with Merck CEO

LONDON, March 1, 2010 /PRNewswire-FirstCall/ — Merck, the global
pharmaceutical and chemical company, announced it is to acquire all
outstanding shares of Millipore, the US life sciences company, for US$ 107
per share in cash, or a total transaction value, including net debt, of
approximately EUR 5.3 billion (US$ 7.2 billion), creating a world-class
partner for the life science sector.

In a video interview on broadcaster http://www.cantos.com, Dr Karl-Ludwig
Klay, Merck Chief Executive, said the transaction was “truly
transformational” for Merck’s Chemicals business.

“We believe that the acquisition is very compelling and fully in line
with our strategy.”

The interview and transcript are available now on
http://www.cantos.com/company/merck.

Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company executives. If you
would like to contact us, please email amanda.alexander@cantos.com or phone
+44-207-936-1352.

SOURCE Merck KGaA